Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4345-4351

  Schurek, Kristen N ^a   Sampaio, Jorge L M ^b   Kiffer, Carlos R V ^b   Sinto, Sumiko ^b   Mendes, Caio M F ^b   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; MEROPENEM; NUCLEIC ACID BINDING PROTEIN; PHOP PROTEIN; PHOQ PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; PMRA PROTEIN; PMRB PROTEIN; POLYMYXIN B; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; INCUBATION TIME; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; OPERON; OUTER MEMBRANE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; PROMOTER REGIONS, GENETIC; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION FACTORS;

EID: 70349324697     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01267-08     Document Type: Article

References (24)

1. Bliss, E. A., C. A. Chandler, and E. B. Schoenbach. 1949. In vitro studies of polymyxin. Ann. N. Y. Acad. Sci. 51:944-951.
2. Chabbert, Y. A., and J. C. Patte. 1961. Type and characteristics of the bacterial resistance to colistine. Ann. Inst. Pasteur (Paris) 100(Suppl.):44-52. (In French.)
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Ernst, R. K., S. M. Moskowitz, J. C. Emerson, G. M. Kraig, K. N. Adams, M. D. Harvey, B. Ramsey, D. P. Speert, J. L. Burns, and S. I. Miller. 2007. Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J. Infect. Dis. 196:1088-1092.
5. Ernst, R. K., E. C. Yi, L. Guo, K. B. Lim, J. L. Burns, M. Hackett, and S. I. Miller. 1999. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561-1565.
6. Falagas, M. E., and S. K. Kasiakou. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
7. Gilleland, H. E., and R. S. Conrad. 1982. Chemical alterations in cell envelopes of polymyxin-resistant mutants of Pseudomonas aeruginosa grown in the absence or presence of polymyxin. Antimicrob. Agents Chemother. 22: 1012-1016.
8. Gilleland, H. E., and L. B. Farley. 1982. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism. Can. J. Microbiol. 28:830-840.
9. Gilleland, H. E., and R. G. Murray. 1976. Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa. J. Bacteriol. 125:267-281.
10. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
11. Hancock, R. E. W., T. Falla, and M. Brown. 1995. Cationic bactericidal peptides. Adv. Microb. Physiol. 37:135-175.
12. Koch-Weser, J., V. W. Sidel, E. B. Federman, P. Kanarek, D. C. Finer, and A. E. Eaton. 1970. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72:857-868.
13. Loh, B., C. Grant, and R. E. W. Hancock. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551. (Pubitemid 14018094)
14. Macfarlane, E. L., A. Kwasnicka, and R. E. W. Hancock. 2000. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
15. Macfarlane, E. L., A. Kwasnicka, M. M. Ochs, and R. E. W. Hancock. 1999. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
16. 2+- induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188:3995-4006.
17. McPhee, J. B., S. Lewenza, and R. E. W. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
18. Moskowitz, S. M., R. K. Ernst, and S. I. Miller. 2004. PmrAB, a twocomponent regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579.
19. Murray, P. R. 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
20. Peterson, A. A., R. E. W. Hancock, and E. J. McGroarty. 1985. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J. Bacteriol. 164:1256-1261.
21. Salunkhe, P., C. H. Smart, J. A. Morgan, S. Panagea, M. J. Walshaw, C. A. Hart, R. Geffers, B. Tummler, and C. Winstanley. 2005. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J. Bacteriol. 187:4908-4920.
22. Schindler, M., and M. J. Osborn. 1979. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 18:4425-4430. (Pubitemid 10247843)
23. Traub, W. H. 1982. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B. Chemotherapy 28:363-368.
24. Winstanley, C., M. G. Langille, J. L. Fothergill, I. Kukavica-Ibrulj, C. Paradis- Bleau, F. Sanschagrin, N. R. Thomson, G. L. Winsor, M. A. Quail, N. Lennard, A. Bignell, L. Clarke, K. Seeger, D. Saunders, D. Harris, J. Parkhill, R. E. Hancock, F. S. Brinkman, and R. C. Levesque. 2009. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res. 19:12-23.